Dr. Isaacs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10201 Carnegie Ave
Cleveland, OH 44106Phone+1 866-223-8100
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2019 - 2022
- Duke University HospitalResidency, Hematology and Medical Oncology, 2016 - 2022
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2016
Certifications & Licensure
- OH State Medical License 2022 - 2026
- NC State Medical License 2016 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsActivated Coagulation Time and Hepcon Protamine Titration Device to Manage Unfractionated Heparin During Cardiopulmonary Bypass in a Hemophilia A Patient on EmicizumabJames Isaacs, Ian J. Welsby, Jacob N. Schroder, Oluwatoyosi A. Onwuemene
Journal of Cardiothoracic and Vascular Anesthesia. 2021-11-01 - 10 citationsTranscriptional and epigenetic regulators of human CD8T cell function identified through orthogonal CRISPR screens.Sean R McCutcheon, Adam M Swartz, Michael C Brown, Alejandro Barrera, Christian McRoberts Amador
Nature Genetics. 2023-12-01 - 2 citationsOrthogonal CRISPR screens to identify transcriptional and epigenetic regulators of human CD8 T cell function.Sean R McCutcheon, Adam M Swartz, Michael C Brown, Alejandro Barrera, Christian McRoberts Amador
Biorxiv. 2023-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: